Vancomycin Reduction Practices (VRP) in the NICU
Part of paid clinical trials in Modesto, California.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT06772675
- Status
- Recruiting
Conditions
- Antibiotic Stewardship
- Neonatal Sepsis, Late-Onset
- Vancomycin
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- External Facilitation — BEHAVIORALDesignated external facilitators will conduct monthly meetings with local champions at each site. Designated facilitators will follow the developed facilitation guide, that includes content area to cover in each meeting, case scenarios as examples, and tips on how to communicate and support the internal facilitators. The goal is to enable problem-solving and support the local champion in implementing VRP with fidelity
Study Details
This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.
Key Dates
- Start date
- Jun 2, 2025
- Status verified
- Jun 2025
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 13 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Sites receiving external facilitationSites will receive guidance from an external facilitator to support uptake of the VRP.
- No Intervention: Sites not receiving external facilitationSites will not receive guidance from an external facilitator.
Primary Outcome Measure
Fidelity of VRP use [ Time Frame: 2.5 years - From beginning of implementation phase to the end of the sustainment phase ]
Central Contacts
- Kayla Gilpin215-573-3976
- Morgan Gabbert267-233-3150
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kaiser Permanente Modesto Medical Center | Modesto | California | 95356 | |
| Kaiser Permanente East Bay - Oakland Medical Center | Oakland | California | 94611 | |
| Kaiser Permanente Roseville Medical Center | Roseville | California | 95661 | |
| Kaiser Permanente San Francisco Medical Center | San Francisco | California | 94115 | |
| Kaiser Permanente San Leandro Medical Center | San Leandro | California | 94577 | |
| Kaiser Permanente Santa Clara Medical Center | Santa Clara | California | 95051 | |
| Kaiser Permanente Walnut Creek Medical Center | Walnut Creek | California | 94596 | |
| Medical Center of Princeton | Plainsboro | New Jersey | 08536 | |
| Virtua Voorhees | Voorhees Township | New Jersey | 08043 | |
| Lancaster General Hospital | Lancaster | Pennsylvania | 17602 | |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | |
| Pennsylvania Hospital | Philadelphia | Pennsylvania | 19107 | |
| Chester County Hospital | West Chester | Pennsylvania | 19380 |
Find similar trials in Modesto, CA
Related Studies
- Lung Ultrasound for Guiding Antibiotic Use in Pediatric PneumoniaRecruiting · Meyer Children's Hospital IRCCS · San Diego, California
- Antibiotic Usage Prior to OnabotulinumtoxinA InjectionRecruiting · Benaroya Research Institute · Stony Brook, New York
- Reducing Overuse of Antibiotics at Discharge HomeEnrolling By Invitation · University of Utah · Salt Lake City, Utah
- Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug ReactionsPHASE1/PHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland